Immunogenicity Testing Software

The Sapio Immunogenicity Testing Software is designed for the precise detection, tracking, and management of immune responses in patients treated with biologic drugs. This is crucial as biologics can trigger the production of anti-drug antibodies (ADA), potentially compromising drug efficacy and patient safety. The platform integrates seamlessly with laboratory systems, facilitating efficient workflows for ADA and neutralizing antibody (NAb) testing while ensuring compliance with regulatory standards.

The software supports a comprehensive immunogenicity testing workflow, including screening, confirmatory, titer, and NAb assays. This ensures streamlined handling of all aspects of ADA and NAb detection. With its electronic laboratory notebook (ELN) integration, Sapio captures, stores, and reports all results in compliance with FDA and EMA guidelines.

Sapio's platform offers automated and customizable cut-point calculations, ensuring consistent and precise assay result interpretation while minimizing manual data handling errors. Pre-built instrument integrations and analytics automate data processing, stability assessments, and selectivity measurements, generating detailed and customizable reports.

Key features of the Sapio Immunogenicity platform include:

• ADA and NAb Assay Support: Manage ADA screening, confirmatory, titer, and NAb assays within a single platform.
• Cut Point and Sensitivity Calculations: Automate complex calculations to ensure assay accuracy and reliability.
• FDA/EMA Compliance: Ensure all assay results meet regulatory standards, including sensitivity, selectivity, specificity, and precision.
• Reagent and Metadata Management: Track all reagents used in testing and link results to patient data, study time points, and treatment details.
• Customizable Reporting: Generate comprehensive reports accommodating all assay parameters, from titer levels to drug response curves.
• Automated Data Analysis: Incorporate advanced tools like JMP for precise analysis of ADA and NAb results.

Sapio's solution is a critical component of biological drug development and safety monitoring, supporting the entire tiered testing strategy from ADA screening to NAb assays. It ensures precise and accurate performance of all steps, minimizing risks and ensuring compliance with regulatory standards.